←
Joey's Wings Foundation116 posts
Joey's Wings Foundation avatar

Joey's Wings Foundation

@Joeyswings

We fund research on MiT family translocation renal cell carcinoma and TFE3-rearranged PEComas in children and young adults.

◷ Joined March 2017▧ 50 Photos and videos
Joey's Wings Foundation avatar
Joey's Wings Foundation@Joeyswings·Sep 20

The fact that there’s such a wall made me sad. The fact that this wall is so long made me sick. The fact that l had to find my boy’s name among 6,000 children left me crushed. A child dying from cancer is wrong. No mother has to find her child’s picture on such a wall.

Post attachmentPost attachmentPost attachment
Joey's Wings Foundation avatar
Joey's Wings Foundation@Joeyswings·Apr 22

Another year of sponsoring young investigators from kidney cancer community to attend 2026 AACR. May this experience broaden their perspectives, deepen their learning, and inspire them to pursue meaningful careers in cancer research!

Post attachment
Joey's Wings Foundation avatar
Joey's Wings Foundation@Joeyswings·7 Dec 2025

RNA binding by TFE3 fusion partners facilitates biomolecular condensate formation, which enhances RNAPII activity to drive pro-oncogenic transcriptional programs. PSPC1 is identified as a key co-condensate component. Can we dissolute TFE3 onco- fusion condensates?

Post attachment
Prathyusha Konda ✨ avatar
⟳ Joey's Wings Foundation retweeted
Prathyusha Konda ✨@labratprats·14 Oct 2025

Despite distinct genetic and transcriptional programs, tRCC and ccRCC share a VCAM1⁺ proximal tubule origin. Some tRCCs, however, may arise from other kidney lineages - plasticity that could explain its varied histology and presence of TFE3 fusions in ASPS and PEComa.

Post attachment
Kaushal Asrani avatar
⟳ Joey's Wings Foundation retweeted
Kaushal Asrani@AsraniKaushal·16 Oct 2025

Excited to finally share our latest study on #TranslocationRCC #PEComas @NatureComms! We generated the first ever, murine transgenic kidney tumor models of SFPQ-TFE3 - the most common MiT/TFE gene fusion implicated in both, tRCC and PEComas (Perivascular Epitheloid neoplasms). We describe a novel role for this fusion in regulating #mTORC1-driven lineage plasticity, with transcriptional downregulation of critical nephric lineage transcription factors like PAX8, that perfectly recapitulate human renal PEComas. Additionally, we nominate the lysosomal V-ATPase complex as a central regulator of mTORC1 activity in tRCC, and a target-rich environment for therapeutic intervention in this deadly disease. Grateful to all the co-authors, collaborators, reviewers, editors and funding sources who made this study possible! @adriannaamendes @LotanLab @eddieimada @MasayaBaba2 @terry_watnickmd @WMarstonLinehan @PeterArgani @yasserged @rmelias2 @nirmishsingla @allaf_mo @Joeyswings @KidneyCancer @kidneycan @CDMRP nature.com/articles/s41467-0…

Post attachment
Joey's Wings Foundation avatar
Joey's Wings Foundation@Joeyswings·19 Jul 2025

Life can be incredibly cruel. 14, what a beautiful age. Austen from Missouri was diagnosed with TFE3 rearranged PEComa overlapping with tRCC only 5 months ago. She passed away this morning. This hurts like hell.

Post attachment
Joey's Wings Foundation avatar
Joey's Wings Foundation@Joeyswings·19 Jul 2025

Much respect to @srviswanathan recipient of Kidney Cancer Innovation/Discovery Grants! Rare subtype like tRCC often received less funding and attention. It takes dedication, creativity, and compassion to tackle diseases that are poorly understood and harder to treat. #KCRS25

Post attachment
Michael Serzan, MD avatar
⟳ Joey's Wings Foundation retweeted
Michael Serzan, MD@MikeSerzanMD·31 May 2025

🗣️Kidney Cancer Oral Abstracts #ASCO25 👉Abs4521: Dr #JAmesGeller presenting Nivo/Axitinib vs Nivo in pts with translocation RCC #AREN1721 🩺Clinical implications: - Nivo/Axitinib (n=6) showed early efficacy ORR 33% and mPFS 10mo - #TranslocationRCC remains a disease of unmet need Further Reading 📖Integrative clinical and molecular characterization of translocation renal cell carcinoma @ZiadBakouny @srviswanathan 🔗shorturl.at/aopSM 📖A genetic basis for sex differences in Xp11 translocation renal cell carcinoma @m_achom 🔗shorturl.at/3Vfbu -------------------------------------------------------- n = 13 Median Age 16 (7-42) 9/13 under 18yo, 9/13 male 💉 Nivo + Axitinib (n=6) ORR 33% mPFS 10.5mo 💉 Nivo alone (n=5) ORR 0%. mPFS 1.8mo 💉 Axitinib alone (n=2) ORR 0% 👥@DrChoueiri @montypal @AlbigesL @TiansterZhang @DrRanaMcKay @tompowles1 @brian_rini @BraunMDPhD @DrKarieRuncie @PBarataMD @PavlosMsaouel @yekeduz_emre @DrYukselUrun @ReneeSaliby @drenriquegrande @bavilima @DRBakaloudiMD @ReginaBarCar @crisbergerot @kidneycan @KidneyCancer @ASCO @oncoalert @OncBrothers

Post attachmentPost attachment